Dalteparin vs Unfractionated Heparin For The Prevention Of Venous Thromboembolism (VTE) In Hospitalized Acutely Ill Medical Patients

Clinical trial NCT00445328 · TERMINATED

Trial details

NCT number: NCT00445328
Sponsor: Pfizer
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Venous Thromboembolism

Start date: 2007-06-01
Primary completion: 2008-07-01
Enrollment: 84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.